Atg7 (but not Atg3), beclin-1, and LC3B expressions were lower in the brain homogenates of DS mice than in wild-type controls and were increased after treatment of the mice with the CBS inhibitor (Fig. 15). The gene discussed is MAP1LC3B; the disease is Dravet syndrome.